Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

An addax had skin cancer that spread to lymph nodes and was euthanized.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Lighter skin types respond better to narrowband UVB therapy for cutaneous T-cell lymphoma than darker skin types.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

A rare type of skin lymphoma was identified, affecting hair follicles and sweat glands.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

A sugar glider had a rare skin cancer that worsened despite treatment, highlighting the need for thorough checks in exotic pets.

Repeated biopsies are crucial for managing lupus panniculitis when initial treatments fail.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

A patient with leukemia/lymphoma also had multiple autoimmune diseases, suggesting a link between them.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Autoimmune reactions may cause both alopecia areata and HAM.

Scalp involvement in primary cutaneous lymphomas is common and can be aggressive, requiring careful attention.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Follicular mycosis fungoides can look like a B-cell lymphoma, making diagnosis difficult.

Tigers had a skin condition causing hair loss and inflammation, but the cause is unknown and treatment didn't work.